DEF: StableX Seeks Shareholder Approval for $7M Capital Raise, Equity Plan

Sentiment:

Definitive Proxy Statement


๐Ÿ“‹All filings for Ayro, INC

StableX Technologies, Inc. calls a special meeting to approve a $7 million private placement and an increase in its long-term incentive plan shares.

Capital raiseThe company entered into a Securities Purchase Agreement on August 4, 2025, for a private placement.The private placement closed on August 8, 2025, yielding approximately $7 million in gross proceeds.It involved the sale of 7,000 shares of Series I convertible preferred stock and warrants to acquire up to 875,000 shares of common stock to investors.Placement agents (GP Nurmenkari Inc. and Palladium Capital Group, LLC) also received warrants to purchase an aggregate of 140,000 shares of common stock.The company is seeking stockholder approval for the issuance of these underlying shares to comply with Nasdaq Listing Rule 5635(d), as the potential issuance exceeds 20% of outstanding common stock.The Series I Preferred Stock has an initial conversion price of $8.00 per share and warrants have an initial exercise price of $8.00 per share, both subject to price-based adjustments.The Series I Preferred Stock carries a 7% annual dividend, compounded quarterly, and is redeemable in equal installments starting November 30, 2025, until February 4, 2027.

Summary

  • StableX Technologies, Inc. is holding a Special Meeting of Stockholders on October 3, 2025, to vote on three key proposals.
  • The first proposal seeks authorization for the issuance of common stock underlying Series I convertible preferred stock and warrants, issued in a private placement that raised approximately $7 million.
  • This issuance is required to comply with Nasdaq Listing Rule 5635(d) as it represents more than 20% of the company's outstanding common stock prior to the transaction.
  • The private placement involved the sale of 7,000 shares of Series I Preferred Stock (convertible into up to 875,000 common shares at $8.00/share) and warrants to acquire up to 875,000 common shares at $8.00/share.
  • Additionally, placement agents received warrants for 140,000 common shares at $8.00/share.
  • The second proposal is to approve the Fourth Amendment to the Long-Term Incentive Plan, increasing the total number of shares authorized for issuance under the plan by 135,627 to 400,000 shares.
  • The third proposal is to approve an adjournment of the Special Meeting, if necessary, to solicit additional proxies.
  • As of the Record Date, September 5, 2025, there were 888,978 shares of Common Stock outstanding.
  • The Series I Preferred Stock carries a 7% annual dividend, compounded quarterly, increasing to 15% upon a Triggering Event.
  • The company's cash and cash equivalents were approximately $5.1 million as of June 30, 2025.
  • The Board unanimously recommends voting FOR all three proposals.

Sentiment

Score: 6

Explanation: The company successfully raised $7 million, which is a positive for its funding requirements. However, this capital raise comes with significant potential dilution for existing shareholders and introduces complex preferred stock terms and covenants. The need for shareholder approval for the issuance, due to Nasdaq rules, highlights the dilutive nature of the transaction. The increase in the incentive plan is a standard practice for talent retention.

Positives

  • Successfully secured approximately $7 million in gross proceeds from a private placement to address cash and funding requirements.
  • The private placement was deemed necessary by the Board after considering other infeasible alternatives.
  • The proposed increase in the Long-Term Incentive Plan shares aims to attract and retain key talent, which is crucial for business success.
  • Holding a virtual special meeting enables greater stockholder attendance and participation, improves efficiency, and reduces costs and environmental impact.

Negatives

  • The potential issuance of up to 1,890,000 underlying shares (from Series I Preferred Stock, Warrants, and Placement Agent Warrants) could result in significant dilution for existing common stockholders.
  • The Series I Preferred Stock ranks senior to all other capital stock (except Series H-7 Preferred Stock) regarding dividends, distributions, and liquidation payments.
  • The company is prohibited from certain "Dilutive Issuances" and "Subsequent Placements" without stockholder approval for the Issuance Proposal, limiting future financing flexibility.
  • Failure to obtain stockholder approval for the Issuance Proposal would require the company to incur additional costs by holding further stockholder meetings every 90 days.
  • Iroquois Capital Investment Group, LLC and Iroquois Master Fund Ltd., significant beneficial owners, may acquire a majority of voting power if the Issuance Proposal is approved.

Risks

  • Dilution: The potential issuance of up to 1,890,000 shares of Common Stock underlying the Series I Preferred Stock, Warrants, and Placement Agent Warrants will increase the number of shares outstanding, causing significant dilution of current stockholders' percentage ownership, voting power, liquidation value, book and market value, and future earnings.
  • Market Price Decline: The issuance or resale of Common Stock from the private placement could cause the market price of the company's Common Stock to decline.
  • Anti-Takeover Effect: The increased number of issued shares could have an incidental anti-takeover effect by diluting stock ownership of parties seeking control, potentially discouraging mergers, tender offers, or proxy contests.
  • Nasdaq Delisting Risk: Failure to obtain stockholder approval for the Issuance Proposal could lead to non-compliance with Nasdaq Listing Rule 5635(d), potentially risking delisting.
  • Preferred Stock Seniority: The Series I Preferred Stock ranks senior to common stock (and junior to Series H-7 Preferred Stock) in terms of dividends, distributions, and liquidation, potentially impacting common stockholders' recovery in adverse scenarios.
  • Triggering Events: The Series I Preferred Stock Certificate of Designations includes "Triggering Events" (e.g., failure to pay amounts due), which could allow holders to demand cash redemption at a premium, creating financial pressure.
  • Covenant Restrictions: The company is subject to affirmative and negative covenants regarding indebtedness, liens, repayment, cash dividends (other than Series I), and asset transfers, which could limit operational flexibility.
  • Cash Reserve Requirement: The company is required to maintain unencumbered, unrestricted cash and cash equivalents equal to at least 50% of the aggregate stated value of outstanding Series I Preferred Stock, potentially tying up capital.
  • Uncertainty of Future Issuances: The exact magnitude of dilutive effect cannot be conclusively determined due to potential adjustments to conversion and exercise prices and the company's lack of control over conversion/exercise by holders.

Future Outlook

The company anticipates that the private placement proceeds will address its cash and funding requirements. The proposed increase in the Long-Term Incentive Plan shares is expected to provide flexibility in compensation methods to attract and retain key talent and promote business success. The company plans to publish voting results in a Form 8-K within four business days following the Special Meeting.

Management Comments

  • "You are cordially invited to attend the 2025 Special Meeting of Stockholders of StableX Technologies, Inc. to be held at 10:00 a.m., New York time, on October 3, 2025."
  • "We have decided to hold this special meeting virtually via live webcast on the internet because hosting a virtual special meeting enables greater stockholder attendance and participation from any location around the world, improves meeting efficiency and our ability to communicate effectively with our stockholders, and reduces the cost and environmental impact of the special meeting."
  • "Your vote is very important. Whether or not you expect to be present at the special meeting, please vote as promptly as possible to ensure your representation and the presence of a quorum at the special meeting."
  • "On behalf of the Board, I urge you to submit your proxy as soon as possible, even if you currently plan to attend the meeting virtually."
  • "We believe that the Private Placement, which yielded aggregate gross proceeds of approximately $7 million, was necessary in light of our cash and funding requirements."
  • "At the time of the Private Placement, our Board considered numerous alternatives to the transactions, none of which proved to be feasible or, in the opinion of our Board, would have resulted in aggregate terms equivalent to, or more favorable than, the terms obtained in the Private Placement."
  • "We believe that operation of the Plan is a necessary and powerful tool in enabling us to attract and retain the best available personnel for positions of substantial responsibility; to provide additional incentive to key employees, key contractors, and non-employee directors; and to promote the success of our business."
  • "We believe there is an insufficient number of shares remaining under our Plan to meet our current and projected needs."
  • "It is the judgment of the Board that the Incentive Plan Amendment is in the best interest of the Company and its stockholders."

Industry Context

This filing reflects common corporate governance practices for publicly traded companies, including seeking shareholder approval for significant equity issuances and adjustments to long-term incentive plans. The private placement highlights the ongoing need for capital raising in the technology sector, especially for companies that may not have immediate access to traditional public offerings or require specific financing structures. The emphasis on virtual meetings aligns with broader trends in corporate efficiency and accessibility. The increase in equity compensation shares is a standard mechanism used across industries to attract and retain talent in competitive markets.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Stockholder Meeting FormatTransitioned to a virtual-only format for the Special Meeting to enhance attendance, efficiency, and reduce costs/environmental impact.October 3, 2025Increases accessibility for global stockholders but eliminates in-person attendance option.
Equity Incentive Plan AmendmentProposed Fourth Amendment to the Long-Term Incentive Plan to increase authorized shares by 135,627 to a total of 400,000 shares.Upon stockholder approvalAims to improve ability to attract and retain key employees, contractors, and non-employee directors, but could lead to further dilution.
Voting Rights ClarificationDetailed explanation of voting rights for Common Stock, Series H-6, H-7, and I Preferred Stock, including beneficial ownership limitations and specific exclusions (Series I holders cannot vote on Issuance Proposal).September 5, 2025Ensures clarity on voting power distribution among different share classes for the Special Meeting.
Nasdaq Listing Rule ComplianceSeeking stockholder approval for the issuance of securities in a private placement to comply with Nasdaq Listing Rule 5635(d) regarding issuances exceeding 20% of outstanding common stock.Upon stockholder approvalCrucial for maintaining Nasdaq listing and avoiding penalties or delisting risks associated with non-compliance.
Covenants from Private PlacementAgreed to certain affirmative and negative covenants, including restrictions on dilutive issuances and subsequent placements, and a cash reserve requirement.August 4, 2025Limits the company's financial and strategic flexibility in future capital market activities and imposes liquidity requirements.

Related Party Transactions

  • Iroquois Capital Investment Group, LLC (ICIG) and its affiliate Iroquois Master Fund Ltd. (IMF), which beneficially own more than 5% of the company's voting securities, participated in the Private Placement.
  • ICIG and IMF may acquire rights to a majority of the company's voting power if the Issuance Proposal is approved.

Stakeholder Impact

  • Shareholders: Potential significant dilution of percentage ownership, voting power, and value due to the issuance of common stock underlying the Series I Preferred Stock and Warrants. The market price of common stock could decline.
  • Preferred Stock Holders (Series I): Will receive 7% annual dividends (15% upon Triggering Event) and have redemption rights, providing a preferential return and capital protection.
  • Employees, Contractors, and Non-Employee Directors: Will benefit from the increased pool of shares available under the Long-Term Incentive Plan, enhancing the company's ability to attract and retain talent through equity awards.
  • Investors in Private Placement: Will receive Series I Preferred Stock and Warrants, providing capital appreciation potential and preferential terms, but their full conversion/exercise is contingent on stockholder approval.
  • Nasdaq: The company's compliance with Nasdaq Listing Rule 5635(d) is critical for maintaining its listing status.
  • Company Operations: The $7 million capital raise provides necessary funding for general corporate purposes, supporting ongoing operations and strategic initiatives.

Next Steps

  • Hold the Special Meeting of Stockholders on October 3, 2025, to vote on the Issuance Proposal, Incentive Plan Amendment Proposal, and Adjournment Proposal.
  • If approved, proceed with the issuance of shares underlying the Series I Preferred Stock and Warrants.
  • If the Issuance Proposal is not approved, the company will be required to hold additional stockholder meetings every 90 days to seek such approval and will be limited in issuing 20% or more of its outstanding shares to the Series I Preferred Stock and Warrant holders or Placement Agents.
  • File a current report on Form 8-K with the SEC within four business days following the Special Meeting to publish voting results.
  • Continue to operate under the terms of the Securities Purchase Agreement, Registration Rights Agreement, and Series I Preferred Stock Certificate of Designations.
  • Implement the Fourth Amendment to the Long-Term Incentive Plan if approved by stockholders.

Key Dates

DateDescription
April 21, 2020Original adoption date of the Long-Term Incentive Plan by the Board.
May 28, 2020Stockholder approval date for the original Long-Term Incentive Plan.
November 6, 2020Board adoption date of the First Amendment to the Long-Term Incentive Plan.
December 17, 2020Stockholder approval date for the First Amendment to the Long-Term Incentive Plan.
August 18, 2023Board adoption date of the Second Amendment to the Long-Term Incentive Plan.
September 14, 2023Stockholder approval date for the Second Amendment to the Long-Term Incentive Plan.
September 15, 2023Effective date of a 1-for-8 reverse stock split of Common Stock.
November 25, 2024Board adoption date of the Third Amendment to the Long-Term Incentive Plan.
December 30, 2024Stockholder approval date for the Third Amendment to the Long-Term Incentive Plan.
June 25, 2025Effective date of a 1-for-16 reverse stock split of Common Stock.
June 30, 2025Company's cash and cash equivalents totaled approximately $5.1 million.
July 25, 2025Board determined necessity to raise additional funds for general corporate purposes.
August 4, 2025Date of Securities Purchase Agreement for the Private Placement.
August 5, 2025Date forms of Purchase Agreement, Registration Rights Agreement, Series I Preferred Stock Certificate of Designations, and Warrants were filed with the SEC as exhibits to a Current Report on Form 8-K.
August 6, 2025Series I Preferred Stock Certificate of Designations filed with the Secretary of State for Delaware.
August 8, 2025Closing Date of the Private Placement.
August 12, 2025Form of Certificate of Designations filed as Exhibit 3.1 to the Company's Current Report on Form 8-K.
August 14, 2025Schedule 13G/A jointly filed by Richard Abbe, Kimberly Page, and Iroquois Capital Management L.L.C.
September 5, 2025Record Date for the Special Meeting.
September 8, 2025Board adoption date of the Fourth Amendment to the Long-Term Incentive Plan, subject to stockholder approval.
September 18, 2025Date proxy statement and related materials were mailed to stockholders.
October 2, 2025Deadline for Internet and telephone voting (11:59 p.m. Eastern Time) and for written proxy revocation (noon, New York time).
October 3, 2025Date of the 2025 Special Meeting of Stockholders (10:00 a.m. New York time, virtual).
November 30, 2025Commencement date for equal installment redemptions of Series I Preferred Stock.
December 22, 2025Deadline for stockholder proposals for the 2026 annual meeting to be included in the proxy statement (under Rule 14a-8).
February 4, 2027Maturity Date for Series I Preferred Stock.
February 5, 2026Earliest date for stockholder proposals concerning director nominations or other business for the 2026 annual meeting (outside Rule 14a-8) to be received by the Secretary.
March 7, 2026Latest date for stockholder proposals concerning director nominations or other business for the 2026 annual meeting (outside Rule 14a-8) to be received by the Secretary.
March 20, 2026Deadline for stockholders to provide notice for soliciting proxies in support of director nominees under Rule 14a-19.
April 19, 2026Earliest date for 2026 annual meeting to be considered 'changed by more than 30 days' from 2025 meeting for Rule 14a-8 purposes.
July 18, 2026Latest date for 2026 annual meeting to be considered 'changed by more than 30 days' from 2025 meeting for Rule 14a-8 purposes.

Recommendation

hold

While the $7 million capital raise addresses immediate funding needs and the expanded incentive plan supports talent retention, the significant potential dilution from the private placement (up to 1,890,000 shares on a pre-existing 631,388 shares) presents a substantial overhang for existing common shareholders. The Series I Preferred Stock's preferential terms and the potential for major investors to gain majority voting power further complicate the outlook. Investors should hold to observe the impact of the dilution and the company's ability to leverage the new capital for growth, while monitoring the market's reaction to the increased share count and preferred stock obligations.

Keywords

StableX Technologies, SEC filing, DEF 14A, Proxy Statement, Special Meeting, Stockholder Approval, Private Placement, Series I Preferred Stock, Warrants, Equity Dilution, Nasdaq Listing Rule 5635(d), Long-Term Incentive Plan, Equity Compensation, Capital Raise, Corporate Governance, Shareholder Vote, SBLX

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.